Vadivarhe Speciality Chemicals Ltd
₹ 28.0
4.87%
13 Mar
- close price
About
Incorporated in 2009, Vadivarhe Speciality Chemicals Ltd is in the business of manufacturing Specialty Chemicals, Intermediates & API
Key Points
- Market Cap ₹ 35.8 Cr.
- Current Price ₹ 28.0
- High / Low ₹ 75.4 / 21.0
- Stock P/E 70.2
- Book Value ₹ 2.49
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 1.24 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 11.3 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -3.12%
- The company has delivered a poor sales growth of 4.37% over past five years.
- Company has a low return on equity of -40.2% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13.16 | 13.87 | 19.03 | 26.28 | 35.03 | 25.56 | 32.36 | 28.58 | 26.47 | 21.45 | 43.68 | 40.08 | 40.45 | |
15.41 | 11.18 | 11.52 | 18.89 | 24.64 | 21.80 | 29.97 | 37.82 | 27.01 | 28.24 | 40.22 | 35.48 | 37.45 | |
Operating Profit | -2.25 | 2.69 | 7.51 | 7.39 | 10.39 | 3.76 | 2.39 | -9.24 | -0.54 | -6.79 | 3.46 | 4.60 | 3.00 |
OPM % | -17.10% | 19.39% | 39.46% | 28.12% | 29.66% | 14.71% | 7.39% | -32.33% | -2.04% | -31.66% | 7.92% | 11.48% | 7.42% |
0.05 | 0.11 | 0.11 | 0.14 | 1.05 | 0.45 | 0.40 | 0.37 | 1.08 | 0.66 | 1.09 | 0.47 | 0.41 | |
Interest | 1.10 | 1.02 | 0.89 | 1.21 | 0.85 | 0.77 | 1.11 | 1.37 | 1.32 | 1.69 | 1.61 | 1.83 | 1.15 |
Depreciation | 1.69 | 1.65 | 1.09 | 1.36 | 1.14 | 1.27 | 1.63 | 1.75 | 1.81 | 1.79 | 1.79 | 1.74 | 1.75 |
Profit before tax | -4.99 | 0.13 | 5.64 | 4.96 | 9.45 | 2.17 | 0.05 | -11.99 | -2.59 | -9.61 | 1.15 | 1.50 | 0.51 |
Tax % | -32.06% | 46.15% | 29.61% | 13.51% | 36.51% | 18.43% | -20.00% | -17.93% | 6.56% | 0.00% | 0.00% | 96.67% | |
-3.39 | 0.07 | 3.98 | 4.29 | 6.01 | 1.77 | 0.06 | -9.84 | -2.76 | -9.61 | 1.15 | 0.06 | 0.51 | |
EPS in Rs | -70.07 | 1.45 | 82.27 | 88.67 | 4.97 | 1.38 | 0.05 | -7.70 | -2.16 | -7.52 | 0.90 | 0.05 | 0.40 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 4% |
3 Years: | 15% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | 1% |
5 Years: | -8% |
3 Years: | 26% |
TTM: | 116% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 2% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | -4% |
5 Years: | -37% |
3 Years: | -40% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.84 | 4.84 | 4.84 | 4.84 | 12.09 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 |
Reserves | 5.66 | 5.73 | 9.68 | 12.62 | 11.38 | 14.64 | 14.70 | 4.87 | 2.11 | -7.50 | -6.36 | -6.29 | -9.60 |
16.77 | 14.35 | 11.24 | 10.65 | 12.74 | 9.66 | 20.98 | 19.67 | 23.45 | 24.42 | 26.94 | 26.18 | 31.36 | |
4.26 | 7.75 | 3.67 | 5.09 | 9.52 | 7.13 | 9.28 | 14.00 | 8.84 | 11.97 | 13.08 | 8.94 | 6.40 | |
Total Liabilities | 31.53 | 32.67 | 29.43 | 33.20 | 45.73 | 44.21 | 57.74 | 51.32 | 47.18 | 41.67 | 46.44 | 41.61 | 40.94 |
17.79 | 15.93 | 15.02 | 13.96 | 17.12 | 19.68 | 26.09 | 25.20 | 25.98 | 24.32 | 23.36 | 21.59 | 21.89 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 1.58 | 1.88 | 2.81 | 0.33 | 1.09 | 0.99 | 1.56 | 1.58 |
Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
13.69 | 16.69 | 14.36 | 19.19 | 28.47 | 22.90 | 29.72 | 23.26 | 20.82 | 16.21 | 22.04 | 18.41 | 17.42 | |
Total Assets | 31.53 | 32.67 | 29.43 | 33.20 | 45.73 | 44.21 | 57.74 | 51.32 | 47.18 | 41.67 | 46.44 | 41.61 | 40.94 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.83 | 6.41 | 5.27 | 3.18 | 2.09 | 7.15 | -1.22 | 4.10 | -0.28 | 1.24 | -0.35 | 2.26 | |
-1.03 | 0.00 | -0.18 | -0.64 | -4.33 | -5.32 | -8.27 | -1.68 | 0.02 | -0.82 | -0.69 | -0.51 | |
3.87 | -6.19 | -4.01 | -3.43 | 1.88 | -1.12 | 9.25 | -2.34 | 0.58 | -0.60 | 1.05 | -2.04 | |
Net Cash Flow | 0.02 | 0.22 | 1.07 | -0.89 | -0.37 | 0.70 | -0.23 | 0.08 | 0.32 | -0.18 | 0.00 | -0.29 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 71.56 | 135.00 | 70.97 | 117.50 | 159.63 | 122.95 | 143.25 | 104.34 | 125.62 | 34.37 | 48.22 | 44.99 |
Inventory Days | 188.83 | 223.98 | 221.86 | 116.68 | 61.66 | 170.63 | 221.62 | 122.32 | 77.40 | 168.42 | 120.82 | 147.37 |
Days Payable | 146.00 | 128.58 | 50.10 | 108.01 | 115.85 | 120.38 | 174.61 | 205.42 | 152.95 | 218.56 | 145.63 | 122.81 |
Cash Conversion Cycle | 114.38 | 230.40 | 242.73 | 126.18 | 105.44 | 173.20 | 190.26 | 21.24 | 50.07 | -15.76 | 23.40 | 69.55 |
Working Capital Days | 85.70 | 76.84 | 102.23 | 86.67 | 140.56 | 143.80 | 155.66 | 61.30 | 76.25 | 37.95 | 56.07 | 81.96 |
ROCE % | -14.79% | 4.41% | 25.77% | 22.61% | 29.66% | 7.86% | 2.88% | -25.06% | -5.34% | -24.02% | 7.61% | 10.15% |
Documents
Announcements
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
12 February 2025 - VADIVARHE SPECIALITY CHEMICALS LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Resignation
12 February 2025 - Vadivarhe Speciality Chemicals Limited has informed regarding Resignation of Mr. Laxmikant Potdar as Chief Financial Officer of the company w.e.f. Jun 01, 2025.
-
Change in Management
12 February 2025 - Vadivarhe Speciality Chemicals Limited has informed about change in Management
-
Outcome of Board Meeting
12 February 2025 - Vadivarhe Speciality Chemicals Limited has informed regarding Board meeting held on February 12, 2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 January 2025 - Vadivarhe Speciality Chemicals Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Business Overview:[1][2]
Company manufactures Active Pharmaceutical Ingredients, bulk drugs, special chemicals, Organic Chemicals, Inorganic Chemicals, Bio-Chemicals and Drug Intermediaries. Raw materials are procured primarily from local market and imported from China. Further, finished products of VSCL are sold locally and
also exported to the countries viz, UK,
USA, Switzerland and Malaysia. Company's manufacturing unit is located at Nashik
with an installed capacity of 150 MTPA